Dallas, TX (PRWEB) January 24, 2013
The patient advocates at the DrugRisk resource center are alerting women using the IUD contraceptive Mirena of new information added to the site showing those filing injury claims have asked that the growing lawsuits be moved to a central federal court rather than a Mirena class action lawsuit.
“The goal of DrugRisk is to improve patient safety through education. By providing the latest drug warnings, recalls and litigation news, patients can have informed discussions with their doctors about drug side effects and decide if they need to seek the advice of a lawyer,” explains DrugRisk representative Ryan Mayer.
DrugRisk has reported that the FDA has received over 45,000 AERS reports of women suffering complications while using the Mirena IUD. Of these, 5079 involved dislocation and 1421 involved migration of the devices, which can perforate or damage the uterine wall.* In more than 6% of cases, patients required hospitalization or surgery.
The resource center has also learned that the FDA warned the maker of Mirena, Bayer, about the marketing of the device in 2009, after they failed to disclose safety risks while claiming the devices could help busy moms with intimacy and make them “look and feel great.”**
Now, with litigation over Mirena perforation growing, DrugRisk reports that plaintiffs have filed a petition requesting cases be consolidated to a special federal Multi-District Litigation court in Ohio instead of a class action lawsuit.*** The petition estimates that, with more than 2 million MIrena users, hundreds of perforation cases may be filed.
Anyone affected by a Mirena device is urged to learn about their legal rights to file a claim. Due to the specialized nature of federal MDL drug injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Mirena lawsuits.
For more information on the research, side effects and litigation news related to Mirena and other medical devices, or to speak with a lawyer, visit http://www.DrugRisk.com.
*FDA AERS Reports for Mirena through June 30, 2012 - drugcite.com/?q=mirena
**NDA 21-225, Mirena (levonorgestrel-releasing intrauterine system) MACMIS # 18166, 12/30/09
***In Re: Mirena IUD Product Liability Litigation, Case No. 1:12-CV-2780; harrismartin.com/media/uploads/documents/DRU-1301-27.pdf